SLC14A2-AS1

Across TCGA pan-cancer cohorts, SLC14A2-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SLC14A2-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SLC14A2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC14A2-AS1 expression acts as an unfavorable survival marker, although some lineages such as ACC and MESO show a favorable association.

ACC, MESO, and PAAD are the cancer types where SLC14A2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.741	0.434	.005	53	view →
MESO	OS	Quartile	All	0.681	0.366	<.001	41	view →
PAAD	OS	Quartile	All	0.766	0.433	<.001	33	view →
SKCM	DFS	Median	All	0.669	0.545	.002	30	view →
UVM	DFS	Quartile	All	0.493	0.812	.023	20	view →
THCA	DFS	Median	All	0.929	0.686	.008	20	view →
LUAD	DFS	Quartile	All	0.829	0.713	.006	19	view →
BRCA	OS	Tertile	III,IV	0.964	0.852	.013	18	view →
SARC	OS	Quartile	All	0.926	0.761	.001	14	view →
ESCA	DFS	Tertile	IV	0.221	0.539	.046	12	view →
CESC	OS	Tertile	III,IV	0.175	0.525	.022	12	view →
CHOL	DFS	Median	All	0.757	0.125	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SLC14A2-AS1–ACC (OS)

Open the ACC breakdown →